Sign in

CIK 0001498382

  • Non-accelerated filer
  • Smaller reporting company

TuHURA Biosciences, Inc./NV

Sign in to watch
Ticker
HURA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
NV
Entity type
Operating
EIN
990360497
Phone
+1 813-875-6600
Business address
10500 UNIVERSITY CENTER DR., SUITE 110, TAMPA, FL, 33612
Former names
Kintara Therapeutics, Inc., DelMar Pharmaceuticals, Inc., Berry Only Inc.
  1. 4 Other acquisition Director acquired 192 shares (other)
  2. 4 Other acquisition CEO acquired 120 shares (other)
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Open-market buy CEO, Director bought 7,500 shares at $1.47 ($11,025)
  11. 4 Open-market buy President, CEO bought 3,000 shares at an average $0.80 ($2,396)
  12. 4 Open-market buy President, CEO bought 4,000 shares at $0.83 ($3,320)
  13. 4 Open-market buy Chief Scientific Officer bought 10,000 shares at $0.60 ($6,000)
  14. 4 Open-market buy President, CEO bought 10,000 shares at $0.60 ($6,000)
  15. 4 Open-market buy Chief Scientific Officer bought 75,000 shares at $0.60 ($45,000)
  16. 4 Open-market buy Director bought 50,000 shares at $0.60 ($30,000)
  17. 4 Open-market buy Director bought 16,666 shares at $0.60 ($10,000)
  18. 4 Open-market buy Chief Financial Officer bought 50,000 shares at $0.60 ($30,000)
  19. 4 Open-market buy President, CEO bought 50,000 shares at $0.60 ($30,000)
  20. 3 Insider Initial Statement of Ownership

Page 13 of 16 · 308 filings